Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.

Publikation

Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.

Wissenschaftlicher Artikel/Review - 02.04.2024

Rudin Salome, Kriemler Lilian, Dittrich Tolga, Zietz Annaelle, Schweizer Juliane, Arnold Markus, Peters Nils, Barinka Filip, Jung Simon, Arnold Marcel, Fischer Urs, Rentsch Katharina M, Christ-Crain Mirjam, Katan Mira, De Marchis Gian Marco

Zitation

Rudin S, Kriemler L, Dittrich T, Zietz A, Schweizer J, Arnold M, Peters N, Barinka F, Jung S, Arnold M, Fischer U, Rentsch K, Christ-Crain M, Katan M, De Marchis G. Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center. Swiss Med Wkly 2024; 154:3633.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Swiss Med Wkly 2024; 154

Veröffentlichungsdatum

02.04.2024

eISSN (Online)

1424-3997

Seiten

3633

Kurzbeschreibung/Zielsetzung

Lipoprotein (a) [Lp(a)] serum levels are highly genetically determined and promote atherogenesis. High Lp(a) levels are associated with increased cardiovascular morbidity. Serum Lp(a) levels have recently been associated with large artery atherosclerosis (LAA) stroke. We aimed to externally validate this association in an independent cohort.